Abiopharma

🔍 Control Empresarial de Capitales S.A. de C.V. (Executive)

Company: PBF Energy Inc. (PBF)

Report Date: 2026-05-04

Detailed Transactions and Holdings:

• Sold 170,000 shares of Class A Common Shares (as defined in Exhibit 99.1 hereto) at $44.753 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 18,718,698.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 30,000 shares of Class A Common Shares (as defined in Exhibit 99.1 hereto) at $45.51 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 18,688,698.00 | transaction_form_type: 4 | Footnotes: F2, F4
• Sold 220,000 shares of Class A Common Shares (as defined in Exhibit 99.1 hereto) at $45.9068 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 18,468,698.00 | transaction_form_type: 4 | Footnotes: F3, F4

Footnotes:

• F1: Weighted average price. These shares were sold in multiple transactions at prices ranging from $44.30 to $45.20 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
• F2: Weighted average price. These shares were sold in multiple transactions at prices ranging from $45.45 to $45.5402 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
• F3: Weighted average price. These shares were sold in multiple transactions at prices ranging from $45.5101 to $46.285 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
• F4: See attached Exhibit 99.1 to this Form 4, which is hereby incorporated herein by reference.